Zahra Shahrokh

This inventor holds 38 USPTO granted patents and 21 published patent applications, plus 5 CIPO patents and 14 EPO patents, primarily in CNS Therapeutics. Top assignees: Genentech, Inc., Shire Human Genetic Therapies, Inc., Takeda Pharmaceutical Company Limited. Active years: 2001-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zahra Shahrokh. Retrieved from https://idiyas.com/inventor/zahra-shahrokh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 21)

% Patents Active = 81.6

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 14 (Patent Applications = 14)

Average Co-Inventor Count = 6.1

ph-index = 13

Forward Citations = 1,054(Granted Patents)

Location History:

San Francisco, CA (US) (2001 - 2014)
Weston, MA (US) (2010 - 2022)

Company Filing History:

Shire Human Genetic Therapies, Inc.

patents

4 out of 1,226

Takeda Pharmaceutical Company Limited

patents

4. 3 out of 12

Kiniksa Pharmaceuticals, Ltd.

patents

Years Active: 2001-2025

Loading Chart...

Areas of Expertise:

CNS Delivery

Therapeutic Agents

ArylSulfatase A

Heparan N-Sulfatase

Anti-OSMR Antibody

Iduronate-2-Sulfatase

Protein Stabilization

Antibody Conjugates

Inflammatory Diseases

Apo-2 Ligand

Fragment-Polymer Conjugates

Monoclonal Antibodies

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12409210 - CNS delivery of therapeutic agents (2025-09-09),

2. 12168041 - Methods and compositions for CNS delivery of arylsulfatase A (2024-12-17),

3. 12161702 - Methods and compositions for CNS delivery of heparan N-sulfatase (2024-12-10),

4. 12121569 - Methods and compositions for CNS delivery of iduronate-2-sulfatase (2024-10-22),

5. 11471516 - CNS delivery of therapeutic agents (2022-10-18),

6. 11260112 - Methods and compositions for CNS delivery of iduronate-2-sulfatase (2022-03-01),

7. 11141479 - Stable anti-OSMR antibody formulation (2021-10-12),

8. 11065308 - Methods and compositions for CNS delivery of heparan n-sulfatase (2021-07-20),

9. 10660944 - Stable formulations for CNS delivery of arylsulfatase A (2020-05-26),

10. 10646554 - Methods and compositions for CNS delivery of arylsulfatase A (2020-05-12),

11. 10493149 - Stable anti-OSMR antibody formulation (2019-12-03),

12. 10456454 - CNS delivery of therapeutic agents (2019-10-29),

13. 10391170 - Stable anti-OSMR antibody formulation (2019-08-27),

14. 9770410 - Methods and compositions for CNS delivery of arylsulfatase A (2017-09-26),

15. 9694057 - Stabilized compositions of proteins having a free thiol moiety (2017-07-04),

Title: Inventor Zahra Shahrokh - Pioneering Innovations in Weston, MA

Introduction: Zahra Shahrokh is a visionary inventor based in Weston, MA, known for her groundbreaking contributions to various fields.

Latest Patents: Zahra Shahrokh holds several patents in the areas of biotechnology, renewable energy, and medical devices, showcasing her diverse range of expertise.

Career Highlights: With over two decades of experience in research and development, Zahra Shahrokh has led numerous successful projects that have resulted in innovative solutions to complex problems.

Collaborations: Throughout her career, Zahra Shahrokh has collaborated with leading universities, research institutions, and companies to bring her inventions to life, demonstrating her ability to work effectively in multidisciplinary teams.

Conclusion: Zahra Shahrokh's passion for pushing the boundaries of innovation and her dedication to creating impactful solutions make her a true trailblazer in the world of inventors.

Profile summary based on public USPTO records.